Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
BAA BENEFIT-TRANSFER METHODS ON DIABETES MEDICAL DEVICES FY24C1IP2 DPCDDepartment of Health and Human Services$699.1K obligationsEnds Mar 12, 2028
NICHD: R&D: BPCA PEDIATRIC DRUG DEVELOPMENT CLINICAL TRIAL INFRASTRUCTURE: SEVERABLEDepartment of Health and Human Services$5.0M obligationsEnds Sep 19, 2027
2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQDepartment of Health and Human Services$2.2M obligationsEnds May 31, 2027
CISA CLINICAL VACCINE SAFETY EVALUATION - CONTRIBUTING CONTRACTOR FUNCTIONSDepartment of Health and Human Services$235.9K obligationsEnds Sep 26, 2017
THIS CONTRACT WILL SUPPORT COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES…Department of Health and Human Services$68.0M obligationsEnds Jul 28, 2027
1500006I DUKE UNIVERSITY; TO 18-0006.B1.0115--06 BASE AWARD; BIOD CAN 8470038 $55,158Department of Health and Human Services$2.4M obligationsEnds Jul 31, 2025
PHASE 1 CLINICAL TRIALDepartment of Health and Human Services$109.7K obligationsEnds Dec 14, 2021
IGF::OT::IGF VTEU PROTOCOL DEVELOPMENT, IMPLEMENTATION AND ASSAYS TASK AREA B-D POPULATION PHARMACOKINETIC ANALYSES TASK ORDER FY.2017.B2C2D2.0053.Department of Health and Human Services$1.1M obligationsEnds Nov 30, 2022
HEALTHY VOLUNTEER STUDY OF CSF FLUID AND ORAL BIOAVAILABILITY OF RR-HNKDepartment of Health and Human Services$405.8K obligationsEnds May 31, 2024
THE PURPOSE OF THIS TASK ORDER IS TO (A) ACQUIRING, PROCURING AND/OR MANUFACTURING MATERIALS REQUIRED FOR THE GENERATION OF A SCALABLE IN VITRO TRANSCRIPTION (IVT) REACTION, THE…Department of Health and Human Services$6.8M obligationsEnds Mar 28, 2027
POPULATION HEALTH RESEARCH SUPPORT - TASK ORDER A: START UP, PREPARATION, AND TEST ENROLLMENT FOR THE TIMING OF DELIVERY (TIME) AIM OF THE STUDY OF PREGNANCY AND NEONATAL HEALTH…Department of Health and Human Services$432.6K obligationsEnds Aug 31, 2024
NATIONAL CORD BLOOD INVENTORYDepartment of Health and Human Services$31.0M obligationsEnds Sep 3, 2036
IGF::OT::IGF NIAID VIROLOGY QUALITY ASSURANCE (VQA)Department of Health and Human Services$24.0M obligationsEnds Jun 20, 2026
A STUDY IN MEDICARE ADVANTAGE FOR REAL WORLD EVIDENCE IN CARDIOVASCULAR DISEASEDepartment of Health and Human Services$1.6M obligationsEnds Jun 28, 2027
IGF::OT::IGF EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY (EQAPOL)Department of Health and Human Services$35.8M obligationsEnds Sep 29, 2024
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2020)Department of Health and Human Services$35.6M obligationsEnds Dec 31, 2030
IGF::OT::IGF NONHUMAN PRIMATE CORE VIROLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENTDepartment of Health and Human Services$6.1M obligationsEnds Dec 14, 2024
"ADVANCED DEVELOPMENT OF A NEUTRALIZING ANTIBODY VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES"Department of Health and Human Services$18.2M obligationsEnds May 31, 2028
INNOVATIONS IN FUNCTIONAL B CELL EPITOPE DISCOVERYDepartment of Health and Human Services$4.6M obligationsEnds Sep 29, 2027
NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENTDepartment of Health and Human Services$5.1M obligationsEnds Mar 29, 2027
BAA: QUANTIFYING PATIENTS' BENEFIT-RISK TRADEOFFS ASSOCIATED WITH PERCUTANEOUS REVASCULARIZATION OPTIONS FOR PERIPHERAL ARTERIAL DISEASE: A COLLABORATIVE EFFORT WITH THE RAPID…Department of Health and Human Services$1.4M obligationsEnds Jun 30, 2024
ADJUVANT COMPARISON AND CHARACTERIZATIONDepartment of Health and Human Services$8.5M obligationsEnds Apr 30, 2028
PROMOTING T CELL RECOVERY AFTER RADIATION INJURY WITH LONG-ACTING INTERLEUKIN 7Department of Health and Human Services$3.5M obligationsEnds Feb 28, 2027
VIROLOGY CORE LABORATORYDepartment of Health and Human Services$1.9M obligationsEnds Dec 14, 2026
2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQDepartment of Health and Human Services$529.6K obligationsEnds Sep 27, 2026